{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:26:51Z","timestamp":1786933611418,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["58\/17\/2020\/PHA\/BMS"],"award-info":[{"award-number":["58\/17\/2020\/PHA\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23wm0125004"],"award-info":[{"award-number":["JP23wm0125004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127767","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:42:55Z","timestamp":1758577375000},"page":"127767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["FliC adjuvant augments protective efficacy of recombinant T2544 antigen against Salmonella Typhiand Paratyphi A by increasing serum antibodies, intestinal secretory immunoglobulin A and T cell memory"],"prefix":"10.1016","volume":"64","author":[{"given":"Suparna","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pujarini","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnali","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichi","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santasabuj","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2025.127767_bb0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15585\/mmwr.mm7207a2","article-title":"Typhoid fever surveillance, incidence estimates, and Progress toward Typhoid conjugate vaccine introduction - worldwide, 2018-2022","volume":"72","author":"Hancuh","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127767_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the global burden of disease study 2017","volume":"19","author":"Typhoid","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127767_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/QCO.0000000000000479","article-title":"Typhoid and paratyphoid fever: a call to action","volume":"31","author":"Gibani","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127767_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1334762","article-title":"Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis","volume":"15","author":"Salerno-Goncalves","year":"2024","journal-title":"Front Immunol"},{"issue":"3&4","key":"10.1016\/j.vaccine.2025.127767_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.25259\/IJMR_1382_2024","article-title":"Typhoid & paratyphoid vaccine development in the laboratory: a review & in-country experience","volume":"160","author":"Chakraborty","year":"2024","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127767_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 - recommendations","volume":"37","author":"World Health","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127767_bb0040","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0045","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2214-109X(22)00466-1","article-title":"Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data","volume":"11","author":"Liang","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127767_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101925","article-title":"Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis","volume":"58","author":"Khanam","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127767_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.945235","article-title":"Paratyphoid fever a: infection and prevention","volume":"13","author":"Xie","year":"2022","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127767_bb0060","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/tmi.12762","article-title":"Enteric fever in India: current scenario and future directions","volume":"21","author":"Divyashree","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2025.127767_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-981-10-7572-8_2","article-title":"Significance of vi negative isolates of Salmonella Enterica Serovar Typhi","volume":"1052","author":"Haque","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127767_bb0070","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.1016180108","article-title":"An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development","volume":"108","author":"Ghosh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"35 Pt B","key":"10.1016\/j.vaccine.2025.127767_bb0075","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1016\/j.vaccine.2017.07.035","article-title":"A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses","volume":"35","author":"Das","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127767_bb0080","article-title":"A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal Salmonella serovars","volume":"14","author":"Haldar","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-024-00812-4","article-title":"Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity","volume":"9","author":"Chakraborty","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127767_bb0090","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/IAI.05484-11","article-title":"Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis","volume":"79","author":"Simon","year":"2011","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127767_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074850","article-title":"Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar typhimurium harboring both FliC and FljB flagella","volume":"8","author":"Eom","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127767_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104252","article-title":"Parenteral immunization of Salmonella typhimurium ghosts with surface-displayed Escherichia coli flagellin enhancesTLR-5 mediated activation of immune responses that protect the chicken against Salmonella infection","volume":"147","author":"Senevirathne","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2025.127767_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5689709","article-title":"Immunization with bivalent Flagellin protects mice against fatal Pseudomonas aeruginosa pneumonia","volume":"2017","author":"Behrouz","year":"2017","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apm.12101","article-title":"Protective efficacy of Pseudomonas aeruginosa type-a flagellin in the murine burn wound model of infection","volume":"122","author":"Faezi","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2025.127767_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2020.01.016","article-title":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","volume":"310","author":"Sadeghi","year":"2020","journal-title":"J Biotechnol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127767_bb0120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4014\/jmb.1112.11079","article-title":"Flagellin administration protects respiratory tract from Burkholderia cepacia infection","volume":"22","author":"Zgair","year":"2012","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127767_bb0125","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.rvsc.2013.07.021","article-title":"Co-administration of flagellin augments immune responses to inactivated foot-and-mouth disease virus (FMDV) antigen","volume":"95","author":"Hajam","year":"2013","journal-title":"Res Vet Sci"},{"issue":"48","key":"10.1016\/j.vaccine.2025.127767_bb0130","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1016\/j.vaccine.2008.08.070","article-title":"New malaria vaccine candidates based on the plasmodium vivax Merozoite surface Protein-1 and the TLR-5 agonist Salmonella typhimurium FliC flagellin","volume":"26","author":"Bargieri","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127767_bb0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.1601357","article-title":"Dual immunization with SseB\/Flagellin provides enhanced protection against Salmonella infection mediated by circulating memory cells","volume":"199","author":"Lee","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2018.11.057","article-title":"Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection","volume":"37","author":"Verma","year":"2019","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127767_bb0145","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","article-title":"Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice","volume":"31","author":"Asadi Karam","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127767_bb0150","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/IAI.00054-09","article-title":"A fusion protein vaccine containing OprF epitope 8, OprI, and type a and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa","volume":"77","author":"Weimer","year":"2009","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79013-x","article-title":"Inserting Omp22 into the flagellin protein, replacing its hypervariable region, results in stronger protection against lethal Acinetobacter baumannii infection","volume":"14","author":"Behrouz","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-018-0433-5","article-title":"Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes","volume":"25","author":"Stepanova","year":"2018","journal-title":"J Biomed Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127767_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006522","article-title":"Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice","volume":"12","author":"Baliban","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127767_bb0180","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/IAI.00157-11","article-title":"Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice","volume":"79","author":"Campodonico","year":"2011","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127767_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064680","article-title":"Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates","volume":"8","author":"Simon","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0190","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/mp500520r","article-title":"Flagellin as carrier and adjuvant in cocaine vaccine development","volume":"12","author":"Lockner","year":"2015","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127767_bb0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.imbio.2019.02.011","article-title":"Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever","volume":"224","author":"Das","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2025.127767_bb0200","series-title":"Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery","first-page":"459","article-title":"Murine models to study acute and chronic bacterial infections","author":"Chakraborty","year":"2020"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127767_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004029","article-title":"Rapidly escalating Hepcidin and associated serum Iron starvation are features of the acute response to Typhoid infection in humans","volume":"9","author":"Darton","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127767_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111585","article-title":"Macrophages and Iron: a special relationship","volume":"9","author":"Recalcati","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.vaccine.2025.127767_bb0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fimmu.2013.00017","article-title":"In vitro intestinal mucosal epithelial responses to wild-type Salmonella Typhi and attenuated Typhoid vaccines","volume":"4","author":"Fiorentino","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127767_bb0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-065X.2008.00689.x","article-title":"Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis","volume":"225","author":"Kirimanjeswara","year":"2008","journal-title":"Immunol Rev"},{"issue":"34","key":"10.1016\/j.vaccine.2025.127767_bb0225","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1016\/j.vaccine.2011.05.095","article-title":"Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice","volume":"29","author":"Nguyen","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127767_bb0230","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127767_bb0235","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1128\/IAI.72.11.6676-6679.2004","article-title":"Mucosal administration of flagellin induces innate immunity in the mouse lung","volume":"72","author":"Honko","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127767_bb0240","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/IAI.73.10.6763-6770.2005","article-title":"Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar typhimurium to potentiate mucosal and systemic responses","volume":"73","author":"Pino","year":"2005","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127767_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin-a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.vaccine.2025.127767_bb0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12896-015-0194-0","article-title":"Hybrid flagellin as a T cell independent vaccine scaffold","volume":"15","author":"Bennett","year":"2015","journal-title":"BMC Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0255","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201116","article-title":"Vi-specific serological correlates of protection for typhoid fever","volume":"218","author":"Jin","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.127767_bb0260","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3389\/fimmu.2019.02582","article-title":"IgA and IgG1 specific to vi polysaccharide of Salmonella Typhi correlate with protection status in a Typhoid fever controlled human infection model","volume":"10","author":"Dahora","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127767_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071394","article-title":"A Salmonella Typhi controlled human infection study for assessing correlation between bactericidal antibodies and protection against infection induced by Typhoid vaccination","volume":"9","author":"Jones","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2025.127767_bb0270","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3389\/fimmu.2017.01916","article-title":"Salmonella Typhi bactericidal antibodies reduce disease severity but do not protect against Typhoid fever in a controlled human infection model","volume":"8","author":"Juel","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145945","article-title":"Differential killing of Salmonella enterica Serovar Typhi by antibodies targeting vi and Lipopolysaccharide O:9 antigen","volume":"11","author":"Hart","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127767_bb0280","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/CVI.00214-16","article-title":"Parenteral vaccination can be an effective means of inducing protective mucosal responses","volume":"23","author":"Clements","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127767_bb0285","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.4049\/jimmunol.1202283","article-title":"Systemic flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node","volume":"189","author":"Flores-Langarica","year":"2012","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127767_bb0290","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127767_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.588952","article-title":"Immunization with outer membrane vesicles derived from major outer membrane protein-deficient Salmonella typhimurium mutants for cross protection against Salmonella Enteritidis and avian pathogenic Escherichia coli O78 infection in chickens","volume":"11","author":"Chen","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127767_bb0300","article-title":"Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0305","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","article-title":"A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity","volume":"74","author":"Lee","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127767_bb0310","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.vaccine.2007.11.084","article-title":"TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines","volume":"26","author":"Enioutina","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127767_bb0315","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI44262","article-title":"Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice","volume":"121","author":"Hammerschmidt","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0320","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/mi.2017.70","article-title":"Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4(+) T cells following parenteral immunization","volume":"11","author":"Frederick","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2025.127767_bb0325","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0330","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/IAI.71.1.40-46.2003","article-title":"Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective","volume":"71","author":"Jiang","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127767_bb0335","doi-asserted-by":"crossref","unstructured":"van Ginkel, F.W., et al., Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract. Infect Immun, 2005. 73(10): p. 6892\u2013902 https:\/\/doi.org\/10.1128\/IAI.73.10.6892\u20136902.","DOI":"10.1128\/IAI.73.10.6892-6902.2005"},{"issue":"39","key":"10.1016\/j.vaccine.2025.127767_bb0340","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1016\/j.vaccine.2012.06.086","article-title":"Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response","volume":"30","author":"Taylor","year":"2012","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2025.127767_bb0345","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.vaccine.2011.05.001","article-title":"Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)","volume":"29","author":"Taylor","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0350","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12874-024-02338-8","article-title":"Challenges and opportunities of translating animal research into human trials in Ethiopia","volume":"24","author":"Abrhaley","year":"2024","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0360","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s42003-021-01978-6","article-title":"A deimmunized and pharmacologically optimized toll-like receptor 5 agonist for therapeutic applications","volume":"4","author":"Mett","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.vaccine.2025.127767_bb0365","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fimmu.2014.00516","article-title":"Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward","volume":"5","author":"Sztein","year":"2014","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127767_bb0370","article-title":"Differential adjuvant activity by Flagellins from Escherichia coli, Salmonella enterica serotype typhimurium, and Pseudomonas aeruginosa","volume":"12","author":"Pang","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127767_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw015","article-title":"Phase 1 safety and immunogenicity study of a Quadrivalent seasonal flu vaccine comprising recombinant hemagglutinin-Flagellin fusion proteins","volume":"3","author":"Tussey","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127767_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005493","article-title":"Development of a glycoconjugate vaccine to prevent invasive Salmonella typhimurium infections in sub-Saharan Africa","volume":"11","author":"Baliban","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127767_bb0385","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2011.10.058","article-title":"Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection","volume":"30","author":"Hong","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127767_bb0390","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/1348-0421.12396","article-title":"Intranasal immunization with a peptide conjugated to Salmonella flagellin induces both systemic and mucosal peptide-specific antibody responses in mice","volume":"60","author":"Qian","year":"2016","journal-title":"Microbiol Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:37:31Z","timestamp":1772843851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":78,"alternative-id":["S0264410X25010643"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127767","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FliC adjuvant augments protective efficacy of recombinant T2544 antigen against Salmonella Typhiand Paratyphi A by increasing serum antibodies, intestinal secretory immunoglobulin A and T cell memory","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127767"}}